智通财经APP获悉，8月8日，全球知名指数公司MSCI宣布2025年8月份的指数季度审议结果。在本次调 整中，映恩生物-B(09606)等多家企业将被纳入MSCI全球小型股指数，正式跻身"全球资产"行列。 此次调整将于8月26日收盘后生效。新纳入公司当日尾盘集合竞价成交将放大，系被动资金集中买入， 短期股价影响有限；但长期来看，将在资金、估值和品牌端持续受益。 ...

Core Viewpoint - The financial performance of Hutchison China MediTech (HCM) for the first half of 2025 shows a decline in total revenue but a significant increase in net profit, driven primarily by the growth of its core product, Fruquintinib [2][6]. Financial Performance - Total revenue for HCM in the first half of 2025 was $277.7 million, down from $305.7 million in the same period last year [2]. - The net profit attributable to HCM was $455 million, a substantial increase from $25.8 million in the previous year [2]. Product Performance - Fruquintinib (FRUZAQLA) sales grew by 25% in overseas markets, contributing significantly to revenue [2][3]. - In the Chinese market, Fruquintinib sales were $43 million, down from $61 million year-on-year, attributed to increased market competition and sales team restructuring [3][4]. - The overall sales of Fruquintinib generated $43.1 million in revenue, showing a slight increase from $42.8 million in the previous year [3]. Market Strategy and Challenges - HCM faces challenges in the Chinese market due to intense competition and the introduction of numerous generic drugs [4][6]. - The company is adjusting its market strategy to regain market share in the colorectal cancer segment, with positive signs of recovery noted in the second quarter of 2025 [4]. - HCM has received approvals for Fruquintinib in over 30 countries, with plans to expand into more markets [3][4]. Future Outlook - HCM has revised its 2025 revenue guidance for oncology/immunology business to between $270 million and $350 million, reflecting delays in milestone revenues from partners [6]. - The company reported a cash balance of $1.36 billion as of June 30, 2025, bolstered by the sale of a non-core joint venture [6]. - HCM aims to leverage its strong cash position to accelerate global development of its ATTC project and explore investment opportunities [6].

Core Insights - JD.com has launched the first dedicated paid membership system for corporate procurement, named JD PLUS Enterprise Membership, aimed at enhancing supply chain capabilities and providing various exclusive benefits to enterprise customers [1][2][3] Group 1: Membership Features - The JD PLUS Enterprise Membership offers eight exclusive benefits, including discounts of up to 95%, free shipping on self-operated products, and a 180-day exchange policy [1][2] - The membership is priced at 99 yuan per year for the classic card and 299 yuan for the premium card, with plans to introduce advanced versions based on customer needs [1] Group 2: Cost Reduction and Efficiency - The membership addresses long-standing issues in corporate procurement, such as high costs for scattered purchases and heavy freight charges, by providing a comprehensive cost-reduction solution [1][2] - A manufacturing company reported a nearly 10% reduction in overall procurement costs after using the JD PLUS Enterprise Membership, along with significant reductions in manpower investment [2] Group 3: Financial Flexibility - The membership includes a "buy now, pay later" service, offering up to 61 days of payment terms and a dynamic credit limit of up to 2 million yuan, effectively providing interest-free loans to alleviate cash flow pressures for enterprises [2] Group 4: Quality Assurance and Customer Support - JD PLUS Enterprise Membership ensures high-quality products and after-sales support across eight major scenarios, with a focus on office supplies, production assistance, and construction [3] - The service integrates resources from well-known brands like Logitech, Haier, and Procter & Gamble, allowing members to access diverse value-added services [3] Group 5: Market Reach and Future Plans - JD.com has served over 8 million active enterprise customers, including more than 30,000 large enterprises and over 90% of Fortune 500 companies operating in China [3] - The company plans to continue enhancing its smart supply chain advantages and the JD PLUS Enterprise Membership service system to create more value for enterprise procurement [3]

Group 1 - The core business of the company is global family wealth management, private banking, and investment banking services [1] - As of 2022, the company managed and invested assets exceeding $3.5 billion, with nearly $2.1 billion in family office management and consulting [1] - The company holds licenses from the Monetary Authority of Singapore and the Cayman Islands SIBL [1] Group 2 - As of the 2024 annual report, the company reported total revenue of 175 million and a net profit of 126 million [2] - On August 7, the company proposed a placement of 201.5 million shares at a price of 2.95 HKD per share, representing an 11.94% discount to the previous closing price [3] - On August 8, the company's stock price increased by 4.92%, reaching 3.2 HKD per share with a trading volume of 442 million HKD [1]

和黄医药（00013.HK），作为李嘉诚家族旗下的重要成员，今天股价遭遇重挫。 早盘，和黄医药股价突现跳水，截至发稿跌幅达15.42%，总市值缩水至207亿港元。消息面上，公司日前发布的2025 年中期业绩显著低于市场预期，引发瑞银等机构下调目标价。 | F9 | 前景权 超级营加 圆线 下具 < ( ) >> | | | | | 21.552(CNY) | | | 和黄医约 立即 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 色0.74% 振 3.54% 额 1.65亿 | | WP | | | 23.700 -4.320 -15.42% | | | | | 0013 交易 | | 2025/03/05-2025/08/08(107日)▼ | | | | | | | | | | | | | | | | HKEX HKD 13:41:45 | | | | | | 间/ ● + | | 30.750 | | | 委比 | 71.38% 委员 | | 17405 | 总量 | 5233.95万 换手 | | 6. ...

正力新能(03677)午后涨超6%，截至发稿，涨5.13%，报11.47港元，成交额2287.16万港元。 此外，截至6月30日恒生综合指数半年度审议考察期结束，调整名单预计将于今年8月22日收市后公布， 所有变动将于9月5日(周五)收市后实施并于9月8日(周一)起生效。华泰证券预计，19只股份或于9月初被 纳入港股通，其中包括正力新能。 消息面上，正力新能近日发布盈喜，预计上半年录得纯利1.98亿至2.43亿人民币，相较去年同期亏损1.3 亿人民币，实现扭亏为盈，主要因多款定点车型量产，动力电池出货量大幅增加，推动销售收入增长； 公司持续推进提质增效改善活动，毛利率有较大的提升；及费用率有较大的下降。 ...

每经记者｜赵雯琪 每经编辑｜文多 被称为奶茶界"双11"的"秋天第一杯奶茶"促销节点落下帷幕。 据霸王茶姬8月8日披露的数据，2025年"秋一杯"（也是指立秋节点促销），霸王茶姬销量环比上涨 200%，同比增长28%。 库迪咖啡8月7日提供给《每日经济新闻》记者的官方数据显示，立秋当天，库迪咖啡整体销量是去年同 期的2.5倍。自8月4日开启"奶茶季"营销活动以来，库迪咖啡爆款产品"流云茉莉轻乳茶"单量（订单 量）较去年同期增长628%。 值得一提的是，8月7日晚11点，美团外卖官方微博发文宣布今年"秋天的第一杯奶茶"活动如期结束，这 是美团参与立秋节点奶茶促销活动的第六个年头，不过美团外卖本次并未发布任何订单数据。 美团外卖在文章中表示，不会发布"连续三天超越1亿单"这种类型的战报。当下，只要DAU（日活跃用 户数）超越1.5亿的App（应用程序）以接近100%的补贴率，撒出数百亿元制造1元购、1毛购、1分 购⋯⋯那这些单量都不难做到，但是美团不想向奶茶注入更多泡沫。 美团同时介绍，今年美团共请300万名骑手提前喝上了秋天第一杯奶茶，邀请了超过2万名奶茶店员按 摩，同时联合了100家茶饮品牌及25万家门店携手 ...

智通财经记者 | 王婷婷 港资房企陆续交出了半年度成绩单。 8月7日，太古地产（01972.HK）也公布2025年中期业绩报告并召开业绩发布会。过去半年，太古地产增收不增利，出现自2010年以来首次中期股东应占溢 利出现亏损。 财报数据显示，2025年上半年，太古地产收入为87.23亿港元，同比增长20%；基本盈利增加15%至44.2亿港元；每股基本盈利0.76港元；第一次中期息每股 0.35港元。其中，基本溢利增长主要得益于出售迈阿密Brickell City Centre相关资产带来的收益。 期内，太古地产股东应占经常性基本溢利同比减少4%，由2024年上半年35.7亿港元减至2025年上半年34.2亿港元，主要反映在香港办公楼租金收入下降，以 及准备在未来数年推出多项住宅买卖项目所涉及的销售和市场推广开支增加。 另外，今年上半年，太古地产录得股东应占呈报亏损为12.02亿港元，与2024年同期的17.96亿港元溢利形成对比。Choice数据显示，这是太古地产自2010年 以来首次中期股东应占溢利出现亏损。 投资物业公平值变动是导致亏损扩大的关键因素。2025 年上半年，投资物业公平值出现46.8亿港元的 ...

花旗发表研究报告，永利澳门次季收入按年持平于8.83亿美元，调整后物业EBITDA按年减10%至2.54亿 美元。经赢率调整后EBITDA达2.66亿美元，大致上符合该行预期。该行指，管理层预计，迈向2025年 底，将面对轻微营运干扰，主要是扩建永利皇宫主席俱乐部博彩区的和改造永利大厦，并预计今年新项 目资本支出为2亿至2.5亿美元。花旗将集团2025年至2027年盈利预测下调2%至8%，维持目标价为6.75 港元，评级为"中性"。 ...

瑞银发布研报称，永利澳门(01128)控股股东永利渡假村(Wynn Resorts)公布，澳门调整后物业EBITDA 为2.54亿美元，较去年同期下降约10%，EBITDA达2.66亿美元，低于预期，主要是博彩表现低于预期。 该行维持永利澳门目标价为6.1港元，其评级为"中性"。 瑞银指，永利澳门管理层预料博彩需求于6、7月加速，调整后EBITDA运行速度为每日330万美元。管 理层将继续进行物业升级改造，以保持竞争力，包括扩建永利皇宫主席俱乐部博彩区，以及翻新永利大 厦客房。管理层预计，活动及娱乐中心的建设将于2028年之后完成，但需获得政府批准。该行指，永利 澳门管理层将今年资本支出指引下调5,000万美元，至2亿至2.5亿美元，明年指引维持不变，为4.5亿至5 亿美元。 ...